Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 USD | +4.42% | -4.35% | +66.67% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.67% | 11.56M | |
+5.47% | 111B | |
+11.01% | 105B | |
-12.21% | 22.34B | |
-3.23% | 21.93B | |
-6.08% | 18.59B | |
-36.52% | 18.12B | |
-10.32% | 16.96B | |
+2.77% | 13.7B | |
+38.95% | 12.45B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Adjusts Chemomab Therapeutics PT to $30 From $42, Maintains Outperform Rating